Abstract:Sphingolipids are structural components in the plasma membranes of eukaryotic cells. Their metabolism produces bioactive signaling molecules that modulate fundamental cellular processes. The segregation of sphingolipids into distinct membrane domains is likely essential for cellular function. This review presents the early studies of sphingolipid distribution in the plasma membranes of mammalian cells that shaped the most popular current model of plasma membrane organization. The results of traditional imaging studies of sphingolipid distribution in stimulated and resting cells are described. These data are compared with recent results obtained with advanced imaging techniques, including super-resolution fluorescence detection and high-resolution secondary ion mass spectrometry (SIMS). Emphasis is placed on the new insight into the sphingolipid organization within the plasma membrane that has resulted from the direct imaging of stable isotope-labeled lipids in actual cell membranes with high-resolution SIMS. Super-resolution fluorescence techniques have recently revealed the biophysical behaviors of sphingolipids and the unhindered diffusion of cholesterol analogs in the membranes of living cells are ultimately in contrast to the prevailing hypothetical model of plasma membrane organization. High-resolution SIMS studies also conflicted with the prevailing hypothesis, showing sphingolipids are concentrated in micrometer-scale membrane domains, but cholesterol is evenly distributed within the plasma membrane. Reductions in cellular cholesterol decreased the number of sphingolipid domains in the plasma membrane, whereas disruption of the cytoskeleton eliminated them. In addition, hemagglutinin, a transmembrane protein that is thought to be a putative raft marker, did not cluster within sphingolipid-enriched regions in the plasma membrane. Thus, sphingolipid distribution in the plasma membrane is dependent on the cytoskeleton, but not on favorable interactions with cholesterol or hemagglutinin. The alternate views of plasma membrane organization suggested by these findings are discussed.

Sphingolipids: membrane microdomains in brain development, function and neurological diseases

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis

Regulation of cellular and systemic sphingolipid homeostasis

Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology

Role of cholesterol and sphingolipids in brain development and neurological diseases

Sphingolipids and their metabolism in physiology and disease

Sphingolipid metabolism in brain insulin resistance and neurological diseases

Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2

Beyond the Cherry-Red Spot: Ocular Manifestations of Sphingolipid-Mediated Neurodegenerative and Inflammatory Disorders.

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Signaling roles of sphingolipids in the ischemic brain and their potential utility as therapeutic targets

Sphingolipid Organization in the Plasma Membrane and the Mechanisms That Influence It

Why do we study sphingolipids?

The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders

Sphingomyelin and Its Role in Cellular Signaling.

The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases

Drug Development in the Field of Sphinogolipid Metabolism

Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives

Tackling the biophysical properties of sphingolipids to decipher their biological roles

Lysophospholipid receptors in neurodegeneration and neuroprotection